Status:

COMPLETED

Flexible Ureteroscopy With Tip-bendable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithotomy for Treatment of 2-3cm Renal Stones

Lead Sponsor:

The First Affiliated Hospital of Guangzhou Medical University

Collaborating Sponsors:

University of Malaya

Ankara University

Conditions:

Urolithiasis

Kidney Stone

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Background: Percutaneous nephrolithotomy (PCNL) is the first-line treatment for renal stones larger than 2 cm according to EAU and AUA guidelines. Advances in flexible ureteroscopy, including smaller ...

Detailed Description

1. Background According to the EAU and AUA guidelines, percutaneous nephrolithomy (PCNL) remains the first-line treatment for renal stones larger than 2 cm. In recent years, advancement in flexibl...

Eligibility Criteria

Inclusion

  • Adults aged ≥ 18 years;
  • American Society of Anesthesiology score 1-3;
  • Renal stones diameter of 2-3 cm confirmed by non contrast-CT;
  • Capable of giving written informed consent, including adherence to the requirements of the trial.

Exclusion

  • Patients with abnormal urinary tract anatomy (such as horseshoe kidney or ileal conduit);
  • Patients with uncontrolled urinary tract infection;
  • Patients with health or other factors that are absolute contraindications to f-URS or mini-PCNL;
  • Patients unable to understand or complete trial documentation.

Key Trial Info

Start Date :

August 21 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 4 2025

Estimated Enrollment :

720 Patients enrolled

Trial Details

Trial ID

NCT06526390

Start Date

August 21 2024

End Date

June 4 2025

Last Update

June 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wei Zhu

Guangzhou, Guangdong, China, 510230